Financial results - PHARMAPLANT SRL

Financial Summary - Pharmaplant Srl
Unique identification code: 14751938
Registration number: J32/510/2002
Nace: 111
Sales - Ron
1.606.428
Net Profit - Ron
124.214
Employees
16
Open Account
Company Pharmaplant Srl with Fiscal Code 14751938 recorded a turnover of 2024 of 1.606.428, with a net profit of 124.214 and having an average number of employees of 16. The company operates in the field of Cultivarea cerealelor (excluzând orezul), plantelor leguminoase şi a plantelor oleaginoase having the NACE code 111.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmaplant Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 1.126.992 1.291.100 1.161.164 885.762 1.150.666 1.226.201 1.508.926 2.038.196 1.612.866 1.606.428
Total Income - EUR 1.150.780 1.302.795 1.223.617 1.132.231 1.155.872 1.365.657 1.431.122 2.019.969 1.883.236 1.843.134
Total Expenses - EUR 1.135.461 1.266.764 1.111.894 1.072.907 1.096.277 1.298.386 1.360.904 1.852.638 1.719.999 1.702.043
Gross Profit/Loss - EUR 15.320 36.031 111.723 59.324 59.594 67.270 70.219 167.331 163.236 141.091
Net Profit/Loss - EUR 10.919 30.376 62.559 50.780 50.191 57.454 61.421 147.021 141.390 124.214
Employees 11 13 15 15 12 12 13 13 15 16
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 0.2%, from 1.612.866 euro in the year 2023, to 1.606.428 euro in 2024. The Net Profit decreased by -16.386 euro, from 141.390 euro in 2023, to 124.214 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmaplant Srl

Rating financiar

Financial Rating -
PHARMAPLANT SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmaplant Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmaplant Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmaplant Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmaplant Srl - CUI 14751938

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 550.097 424.766 476.507 564.658 1.427.315 1.480.623 1.530.909 1.409.595 1.501.585 1.337.324
Current Assets 721.236 818.288 587.102 927.076 1.049.673 755.256 880.927 824.742 1.069.401 833.606
Inventories 347.978 403.720 373.550 619.628 551.336 623.541 537.913 729.429 583.196 484.982
Receivables 364.714 427.058 189.293 299.423 371.134 66.371 291.264 24.435 340.857 336.027
Cash 8.544 -12.491 24.259 8.025 127.203 65.344 51.750 70.878 145.348 12.596
Shareholders Funds 205.980 203.879 262.142 308.111 922.965 954.652 994.903 1.134.871 1.272.820 1.389.921
Social Capital 128.254 126.946 124.798 122.508 120.135 117.858 115.244 115.602 115.251 114.607
Debts 1.052.403 1.075.236 803.176 1.184.512 1.554.734 1.281.432 1.429.646 1.100.087 1.299.208 835.642
Income in Advance 13.164 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "111 - 111"
CAEN Financial Year 111
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 833.606 euro in 2024 which includes Inventories of 484.982 euro, Receivables of 336.027 euro and cash availability of 12.596 euro.
The company's Equity was valued at 1.389.921 euro, while total Liabilities amounted to 835.642 euro. Equity increased by 124.214 euro, from 1.272.820 euro in 2023, to 1.389.921 in 2024.

Risk Reports Prices

Reviews - Pharmaplant Srl

Comments - Pharmaplant Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.